Ligand validation:6MO3

CQG: pyridin-4-ol

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6MO3_CQG_A_1602	79%	7%	0.1	0.945	3.93	1	5	1	1	0	100%	0.83
6MO3_CQG_A_1601	33%	8%	0.18	0.859	3.87	0.91	3	-	0	0	100%	0.99
6MO3_CQG_A_1606	29%	6%	0.237	0.895	3.95	1.27	5	1	0	0	100%	0.91
6MLS_CQG_A_503	51%	7%	0.137	0.89	4	0.95	5	1	2	0	100%	0.88
6MME_CQG_A_503	50%	7%	0.171	0.922	3.91	0.93	5	1	1	0	100%	0.79
6MPD_CQG_A_1002	30%	8%	0.178	0.842	3.88	0.9	3	-	0	0	100%	0.92
6MQQ_CQG_A_601	30%	7%	0.216	0.88	3.85	0.98	5	1	0	0	100%	1
6NV8_CQG_A_1003	14%	9%	0.392	0.945	3.75	0.84	5	-	0	0	100%	0.9
6B4Q_CQG_A_307	87%	33%	0.089	0.961	1.1	1.53	-	2	0	0	100%	0.97

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.